Ong K, Stafford L, McLaughlin S, Lancet EB-T. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of. thelancet.comKL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, BE Dalton. J Duprey Lancet. 2023. thelancet.com. Retrieved from https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01301-6/fulltext?ref=tomecontroldesusalud.com

Kuzan A, Królewicz E, Kustrzeba-Wójcicka I, Lindner-Pawłowicz K, Sobieszczańska M. How diabetes and other comorbidities of elderly patients and their treatment influence levels of glycation products. Int J Environ Res Public Health. 2022;19(12):7524. https://doi.org/10.3390/IJERPH19127524/S1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chilton R, Wyatt J, Nandish S, Oliveros R, Lujan M. Cardiovascular comorbidities of type 2 diabetes mellitus: defining the potential of glucagonlike peptide–1-based therapies. Am J Med. 2011;124(1):S35–53. https://doi.org/10.1016/J.AMJMED.2010.11.004.

Article  CAS  PubMed  Google Scholar 

Maravilla Domínguez MA, de Zermeño González ML, Zavaleta Muñiz ER, Montes Varela VA, Irecta Nájera CA, Fajardo Robledo NS, Zavaleta Muñiz SA. Inflammation and atherogenic markers in patients with type 2 diabetes mellitus. Clínica e Investigación en Arteriosclerosis (English Edition). 2022;34(3):105–112. https://doi.org/10.1016/J.ARTERE.2022.05.001.

Burkitt JM. Principles of electrocardiography. Adv Monitor Proc Small Animal Emerg Crit Care. 2023. https://doi.org/10.1002/9781119581154.ch10.

Article  Google Scholar 

Willem AH. Right ventricular function: the comeback of echocardiography?. Eur J Echocardiograph. 2004;5(2) 99–101. https://doi.org/10.1016/j.euje.2003.12.001.

Hiatt WR, Rogers RK, Brass EP. The treadmill is a better functional test than the 6-minute walk test in therapeutic trials of patients with peripheral artery disease. Circulation. 2014;130(1):69–78. https://doi.org/10.1161/CIRCULATIONAHA.113.007003.

Article  PubMed  Google Scholar 

Gil KE, Pawlak A, Gil RJ, Frontczak-Baniewicz M, Bil J. The role of invasive diagnostics and its impact on the treatment of dilated cardiomyopathy: a systematic review. Adv Med Sci. 2016;61(2):331–43. https://doi.org/10.1016/j.advms.2016.07.001.

Article  PubMed  Google Scholar 

Ahn JM, Zimmermann FM, Arora S, Solberg OG, Angerås O, Rolid K, Rafique M, Aaberge L, Karason K, Okada K, Luikart H. Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation. Eur Heart J. 2021;42(48):4918–29. https://doi.org/10.1093/eurheartj/ehab568.

Article  PubMed  PubMed Central  Google Scholar 

Maisch B, Pankuweit S, Karatolios K, Ristić AD. Invasive techniques—from diagnosis to treatment. Rheumatology. 2006;45(suppl_4):iv32-iv38. https://doi.org/10.1093/rheumatology/kel307.

Alfonso F, Rivero F, Segovia-Cubero J. Early diagnosis of cardiac allograft vasculopathy: biopsy, liquid biopsy, non-invasive imaging, coronary imaging, or coronary physiology? Eur Heart J. 2021;42(48):4930–3. https://doi.org/10.1093/eurheartj/ehab722.

Article  PubMed  Google Scholar 

Vestering M, Schoppen T, Dekker R, Wempe J, Geertzen J. Development of an exercise testing protocol for patients with a lower limb amputation: results of a pilot study. Int J Rehabil Res. 2005;28(3):237–44. https://doi.org/10.1097/00004356-200509000-00006.

Article  PubMed  Google Scholar 

Gill T, DiPietro L, Krumholz HM. Role of exercise stress testing and safety monitoring for older persons starting an exercise program. JAMA. 2000;284(3):342–9. https://doi.org/10.1001/jama.284.3.342.

Article  CAS  PubMed  Google Scholar 

Banerjee A, Newman DR, Van den Bruel A, Heneghan C. Diagnostic accuracy of exercise stress testing for coronary artery disease: a systematic review and meta-analysis of prospective studies. Int J Clin Pract. 2012;66(5):477–92. https://doi.org/10.1111/j.1742-1241.2012.02900.x.

Article  CAS  PubMed  Google Scholar 

Gertz ZM, O’Donnell W, Raina A, Litwack AJ, Balderston JR, Goldberg LR. Application of appropriate use criteria to cardiac stress testing in the hospital setting: limitations of the criteria and areas for improved practice. Clin Cardiol. 2015;38(1):8–12. https://doi.org/10.1002/clc.22340.

Article  PubMed  Google Scholar 

Cao X, Tang X, Feng C, Lin J, Zhang H, Liu Q, …, Shen L. A Systematic Investigation of Complement and Coagulation-Related Protein in Autism Spectrum Disorder Using Multiple Reaction Monitoring Technology. Neurosci Bull. 2023;39(11):1623–1637. https://doi.org/10.1007/S12264-023-01055-4/FIGURES/7.

Tang D, Chen M, Huang X, Zhang G, Zeng L, Zhang G, … Wang Y. SRplot: A free online platform for data visualization and graphing. Plos One. 2023;18(11):e0294236. https://doi.org/10.1371/JOURNAL.PONE.0294236.

Shi J, Wang X, Lyu L, Jiang H, Zhu H-J. Comparison of protein expressions between human livers and the hepatic cell lines HepG2, Hep3B and Huh7 using SWATH and MRM-HR proteomics: focusing on drug-metabolizing enzymes. n.d. https://doi.org/10.1016/j.dmpk.2018.03.003.

Bollineni RC, Fedorova M, Blüher M, Hoffmann R. Carbonylated plasma proteins as potential biomarkers of obesity induced type 2 diabetes mellitus. J Proteome Res. 2014;13(11):5081–93. https://doi.org/10.1021/PR500324Y/SUPPL_FILE/PR500324Y_SI_002.PDF.

Article  CAS  PubMed  Google Scholar 

Singh S, Nguyen H, Michels D, Bazinet H, Matkar PN, Liu Z, Esene L, Adam M, Bugyei‐Twum A, Mebrahtu E, Joseph J. BReast CAncer susceptibility gene 2 deficiency exacerbates oxidized LDL-induced DNA damage and endothelial apoptosis. Physiol Rep. 2020;8:e14481. https://doi.org/10.14814/phy2.14481.

Nikfarjam S, Bu S, Nguyen HC, Rasheed B, Frisbee JC, Singh K. Abstract 15377: investigating the role of breast cancer susceptibility gene 2 in high glucose-induced endothelial dysfunction. Circulation. 2022;146(Suppl_1). https://doi.org/10.1161/CIRC.146.SUPPL_1.15377.

Khatri N, Sagar A, Peddada N, Choudhary V, Chopra BS, Garg V, Garg R, Ashish. Plasma gelsolin levels decrease in diabetic state and increase upon treatment with F‐actin depolymerizing versions of gelsolin. J Diabetes Res. 2014 (1):152075. https://doi.org/10.1155/2014/152075.

Piktel E, Levental I, Durnaś B, Janmey PA, Bucki R. Plasma gelsolin: Indicator of inflammation and its potential as a diagnostic tool and therapeutic target. Int J Mol Sci. 2018;19(9). https://doi.org/10.3390/IJMS19092516.

Noren Hooten N, Mode NA, Kowalik E, Omoniyi V, Zonderman AB, Ezike N, … Evans MK. Plasma gelsolin levels are associated with diabetes, sex, race, and poverty. J Trans Med. 2023;21(1). https://doi.org/10.1186/S12967-023-04026-5.

Zhang Q, Wen XH, Tang SL, Zhao ZW, Tang CK. Role and therapeutic potential of gelsolin in atherosclerosis. J Mol Cell Cardiol. 2023;178:59–67. https://doi.org/10.1016/J.YJMCC.2023.03.012.

Article  CAS  PubMed  Google Scholar 

Bhosale SD, Moulder R, Venäläinen MS, Koskinen JS, Pitkänen N, Juonala MT, … Raitakari OT. Serum proteomic profiling to identify biomarkers of premature carotid atherosclerosis. Sci Rep. 2018;8(1). https://doi.org/10.1038/S41598-018-27265-9.

de la Cuesta F, Zubiri I, Maroto AS, Posada M, Padial LR, Vivanco F, … Barderas MG. Deregulation of smooth muscle cell cytoskeleton within the human atherosclerotic coronary media layer. J Proteom. 2013;82:155–165. https://doi.org/10.1016/J.JPROT.2013.01.032.

Laugesen E, Høyem P, Christiansen JS, Knudsen ST, Hansen KW, Argraves WS, … Rasmussen LM. Plasma levels of the arterial wall protein fibulin-1 are associated with carotid-femoral pulse wave velocity: A cross-sectional study. Cardiovasc Diabetol. 2013;12(1):1–9. https://doi.org/10.1186/1475-2840-12-107/TABLES/3.

Bergmann K, Mańkowska-Cyl A, Kretowicz M, Manitius J, Sypniewska G. Fibulin-1 is associated with cardiovascular risk in non-obese, non-diabetic individuals. Med Res J. 2013;1(1):18–22. Retrieved from https://journals.viamedica.pl/medical_research_journal/article/view/35429

Oxlund CS, Cangemi C, Henriksen JE, Jacobsen IA, Gram J, Schousboe K, … Rasmussen LM. Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertension. J Human Hypertens 2015. 2014;29(1):28–32. https://doi.org/10.1038/jhh.2014.27.

Skov V, Cangemi C, Gram J, Christensen MM, Grodum E, Sørensen D, … Rasmussen LM. Metformin, but not rosiglitazone, attenuates the increasing plasma levels of a new cardiovascular marker, fibulin-1, in patients with type 2 diabetes. Diabetes Care. 2014;37(3):760–766. https://doi.org/10.2337/DC13-1022.

Gagno G, Padoan L, Stenner E, Beleù A, Ziberna F, Hiche C, … Aleksova A. Galectin 3 and galectin 3 binding protein improve the risk stratification after myocardial infarction. J Clin Med. 2019;8(5):570. https://doi.org/10.3390/JCM8050570.

DeRoo EP, Wrobleski SK, Shea EM, Al-Khalil RK, Hawley AE, Henke PK, … Diaz JA. The role of galectin-3 and galectin-3–binding protein in venous thrombosis. Blood. 2015;125(11):1813–1821. https://doi.org/10.1182/BLOOD-2014-04-569939.

Overgaard M, Ravnsborg T, Lohse Z, Bytoft B, Clausen TD, Jensen RB, … Jensen DM. Apolipoprotein D and transthyretin are reduced in female adolescent offspring of women with type 1 diabetes: The EPICOM study. Diabetic Med. 2022;39(7):e14776. https://doi.org/10.1111/DME.14776

Fyfe-Desmarais G, Desmarais F, Rassart É, Mounier C. Apolipoprotein D in oxidative stress and inflammation. Antioxidants. 2023;12:1027, 12(5), 1027. https://doi.org/10.3390/ANTIOX12051027.

Speidl WS, Kastl SP, Huber K, Wojta J. Complement in atherosclerosis: friend or foe? J Thrombosis Haemostasis. 2011. https://doi.org/10.1111/j.1538-7836.2010.04172.x.

Xin Y, Hertle E, van der Kallen CJH, Schalkwijk CG, Stehouwer CDA, van Greevenbroek MMJ. Complement C3 and C4, but not their regulators or activated products, are associated with incident metabolic syndrome: the CODAM study. Endocrine. 2018;62(3):617–27. https://doi.org/10.1007/s12020-018-1712-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Copenhaver MM, Yu CY, Zhou D, Hoffman RP. Relationships of complement components C3 and C4 and their genetics to cardiometabolic risk in healthy, non-Hispanic white adolescents. Pediatr Res. 2020;87(1):88–94. https://doi.org/10.1038/s41390-019-0534-1.

Article  CAS  PubMed  Google Scholar 

Ajjan RA, Schroeder V. Role of complement in diabetes. Mol Immunol. 2019;114:270–7. https://doi.org/10.1016/J.MOLIMM.2019.07.031.

Article  CAS  PubMed  Google Scholar 

Barrachina MN, Sueiro AM, Casas V, Izquierdo I, Hermida-Nogueira L, Guitián E, … García Á. A combination of proteomic approaches identifies a panel of circulating extracellular vesicle proteins related to the risk of suffering cardiovascular disease in obese patients. Proteomics. 2019;19(1–2):1800248. https://doi.org/10.1002/PMIC.201800248.

Nityanand S, Truedsson L, Mustafa A, Bergmark C, Lefvert AK. Circulating immune complexes and complement C4 null alleles in patients operated on for premature atherosclerotic peripheral vascular disease. J Clin Immunol. 1999;19(6):406–13. https://doi.org/10.1023/A:1020506901117/METRICS.

Article  CAS  PubMed  Google Scholar 

Xing Z, Wang Y, Gong K, Chen Y. Plasma C4 level was associated with mortality, cardiovascular and cerebrovascular complications in hemodialysis patients. BMC Nephrology. 2022;23(1). https://doi.org/10.1186/s12882-022-02829-0.

Zhang X, Yin J, Shao K, Yang L, Liu W, Wang Y, … Yang Y. High serum complement component C4 as a unique predictor of unfavorable outcomes in diabetic stroke. Metabol Brain Disease. 2021;36(8):2313–2322. https://doi.org/10.1007/S11011-021-00834-0/METRICS.

Hansmeier N, Buttigieg J, Kumar P, Pelle S, Choi KY, Kopriva D, Chao TC. Identification of mature atherosclerotic plaque proteome signatures using data-independent acquisition mass spectrometry. J Proteome Res. 2018;17(1):164–76. https://doi.org/10.1021/ACS.JPROTEOME.7B00487/ASSET/IMAGES/LARGE/PR-2017-00487A_0005.JPEG.

Article  CAS  PubMed  Google Scholar 

Talusan P, Bedri S, Yang S, Kattapuram T, Silva N, Roughley PJ, Stone JR. Analysis of intimal proteoglycans in atherosclerosis-prone and atherosclerosis-resistant human arteries by mass spectrometry. Mol Cell Proteomics. 2005;4(9):1350–7. https://doi.org/10.1074/MCP.M500088-MCP200.

Article  CAS  PubMed  Google Scholar 

Funderburgh JL, Mitschler RR, Funderburgh ML, Roth MR, Chapes SK, Conrad GW. Macrophage receptors for lumican. A corneal keratan sulfate proteoglycan. Investig Ophthalmol Vis Sci. 1997;38(6):1159–1167

Onda M, Ishiwata T, Kawahara K, Wang R, Naito Z, Sugisaki Y. Expression of lumican in thickened intima and smooth muscle cells in human coronary atherosclerosis. Exp Mol Pathol. 2002;72(2):142–9. https://doi.org/10.1006/EXMP.2002.2425.

Article  CAS  PubMed